Sermorelin troches from GetOPT

Sermorelin (Troche) - 30 QTY

$174.00
Options
Free shipping on all US orders
Got any questions? Contact us

Supplied by U.S. pharmacies.

Description

Product Overview and Formulation Facts

  • Sermorelin is a synthetic peptide consisting of 29 amino acids.
  • The supplied Scriptworks source lists sermorelin in troche form.
  • Sermorelin is not human growth hormone (HGH).[3]

Sermorelin troche is a compounded oral form of a synthetic peptide related to growth hormone-releasing hormone (GHRH).

Clinical Research and Route-Specific Pharmacokinetics

In a published 1993 pharmacokinetic study, Wilton and colleagues compared intravenous and intranasal administration of the peptide in healthy men.[1] Hormone responses differed between routes.[1] The cited Wilton study did not test an oral troche.[1]

Formulation Distinctions and Medical Assessment

Historical regulatory decisions for injectable products do not extend to compounded oral medications.[2][4] The Food and Drug Administration (FDA) previously approved injectable sermorelin products.[2] Those injectable products were later discontinued.[2] A 2013 Federal Register notice determined that those products were not withdrawn from sale for safety or effectiveness reasons.[2] That finding does not verify the stability or efficacy of an oral troche prepared by a compounding pharmacy.[2][4]

Frequently asked questions

What is a sermorelin troche?

A sermorelin troche is a compounded oral dosage form. It contains a synthetic 29-amino-acid peptide related to GHRH.

Is sermorelin the same as human growth hormone?

Sermorelin is not Human Growth Hormone (HGH).[3]

Do oral troches provide the same clinical effects as injections?

The cited Wilton study does not establish bioavailability or clinical outcomes for an oral troche.[1] Wilton and colleagues compared injection and nasal forms and found different hormone responses.[1]

Does historical injection approval apply to this troche?

Historical approval for an injectable sermorelin product does not establish FDA approval of this compounded oral troche.[2][4] The FDA notice addressed discontinued injectable medicines.[2]

Research and information sources

  1. GHRH(1–29) route-comparison study (PubMed 8329825)
  2. FDA Federal Register: historical sermorelin injection determination
  3. Opt Health: Sermorelin Peptide
  4. FDA: Compounding and FDA Questions and Answers
  5. Opt Health: How It Works

Regulatory Status and Safety Considerations

The cited injection and nasal study does not establish the safety profile of this oral troche.[1] Compounded medications are not FDA-approved.[4]

Explore Personalized Care with Opt Health

Opt Health connects patients with licensed physicians for comprehensive biomarker blood tests and clinical evaluations.[5] Your provider examines lab values, medical history, and current medications before recommending a personalized care plan.[5]

Explore Opt care

This content is for informational purposes and does not replace evaluation, diagnosis, or treatment by a qualified medical professional.